Abivax SA (ABVX)
126.14
+0.45
(+0.36%)
USD |
NASDAQ |
Apr 10, 16:00
126.10
-0.04
(-0.03%)
Pre-Market: 20:00
Abivax EPS Diluted (Quarterly) : -1.215 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.743 |
| Eli Lilly & Co. | 7.024 |
| DBV Technologies SA | -1.170 |
| Insmed, Inc. | -1.538 |
| Nicox SA | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -95.40M |
| Total Expenses (Quarterly) | 95.40M |
| Enterprise Value | 9.401B |
| Earnings Yield | -4.29% |
| Normalized Earnings Yield | -3.755 |